Perinatal exposure of patas monkeys to antiretroviral nucleoside reverse-transcriptase inhibitors induces genotoxicity persistent for up to 3 years of age

Journal of Infectious Diseases

Volumn 208, Issue 2, 2013, Pages 244-248

  Olivero, Ofelia A ^a   Torres, Lorangelly Rivera ^a   Gorjifard, Sayeh ^a   Momot, Dariya ^a   Marrogi, Eryney ^a   Divi, Rao L ^a,b   Liu, Yongmin ^a   Woodward, Ruth A ^c   Sowers, Marsha J ^c   Poirier, Miriam C ^a  

^a Center for Cancer Research   (Taiwan)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

abacavir; aneuploidy; centrosomal amplification; Erythrocebus patas; lamivudine; mesenchymal fibroblasts; micronuclei; nevirapine; zidovudine

Indexed keywords

ABACAVIR PLUS LAMIVUDINE; ABACAVIR PLUS LAMIVUDINE PLUS ZIDOVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS ZIDOVUDINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR;

ANEUPLOIDY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DAMAGE; CELL EXPANSION; CENTROSOME; CONTROLLED STUDY; DRUG EFFICACY; FIBROBLAST; GENOTOXICITY; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MESENCHYME CELL; MICRONUCLEUS; NONHUMAN; ONSET AGE; PERINATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROGENY; TOXICITY TESTING;

ABACAVIR; ANEUPLOIDY; CENTROSOMAL AMPLIFICATION; ERYTHROCEBUS PATAS; LAMIVUDINE; MESENCHYMAL FIBROBLASTS; MICRONUCLEI; NEVIRAPINE; ZIDOVUDINE;

ANIMALS; ANIMALS, NEWBORN; ANTI-HIV AGENTS; ERYTHROCEBUS PATAS; FEMALE; HIV-1; HUMANS; MESENCHYMAL STROMAL CELLS; MESODERM; NUCLEOSIDES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL EXPOSURE DELAYED EFFECTS; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 84876906224     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit146     Document Type: Article

References (15)

1. Mofenson LM, McIntyre JA. Advances and research directions in the prevention of mother-to-child HIV-1 transmission. Lancet 2000; 355:2237-44 (Pubitemid 30394338)
2. Poirier MC, Olivero OA, Walker DM, Walker VE. Perinatal genotoxicity and carcinogenicity of anti-retroviral nucleoside analog drugs. Toxicol Appl Pharmacol 2004; 199:151-61 (Pubitemid 39094533)
3. Witt KL, Cunningham CK, Patterson KB, et al. Elevated frequencies of micronucleated erythrocytes in infants exposed to zidovudine in utero and postpartum to prevent mother-to-child transmission of HIV. Environ Mol Mutagen 2007; 48:322-9 (Pubitemid 46536099)
4. Olivero OA, Anderson LM, Diwan BA, et al. Transplacental effects of 3′-azido-2′,3′-dideoxythymidine (AZT): tumorigenicity in mice and genotoxicity in mice and monkeys. J Natl Cancer Inst 1997; 89:1602-8 (Pubitemid 27479720)
5. Olivero OA, Fernandez JJ, Antiochos BB, Wagner JL, St Claire ME, Poirier MC. Transplacental genotoxicity of combined antiretroviral nucleoside analogue therapy in Erythrocebus patas monkeys. J Acquir Immune Defic Syndr 2002; 29:323-9 (Pubitemid 34288884)
6. Borojerdi JP, Ming J, Cooch C, et al. Centrosomal amplification and aneuploidy induced by the antiretroviral drug AZT in hamster and human cells 1. Mutat Res 2009; 665:67-74
7. Walker DM, Malarkey DE, Seilkop SK, et al. Transplacental carcinogenicity of 3′-azido-3′-deoxythymidine in B6C3F1 mice and F344 rats. Environ Mol Mutagen 2007; 48:283-98 (Pubitemid 46536096)
8. Dobrovolsky VN, Shaddock JG, Mittelstaedt RA, et al. Frequency of Hprt mutant lymphocytes and micronucleated erythrocytes in p53- haplodeficient mice treated perinatally with AZT and AZT in combination with 3TC. Environ Mol Mutagen 2007; 48:270-82 (Pubitemid 46536095)
9. Escobar PA, Olivero OA, Wade NA, et al. Genotoxicity assessed by the comet and GPA assays following in vitro exposure of human lymphoblastoid cells (H9) or perinatal exposure of mother-child pairs to AZT or AZT-3TC. Environ Mol Mutagen 2007; 48:330-43 (Pubitemid 46536100)
10. Benhammou V, Warszawski J, Bellec S, et al. Incidence of cancer in children perinatally exposed to nucleoside reverse transcriptase inhibitors. AIDS 2008; 22:2165-77
11. Divi RL, Doerge DR, Twaddle NC, et al. Metabolism and pharmacokinetics of the combination Zidovudine plus Lamivudine in the adult Erythrocebus patas monkey determined by liquid chromatographytandem mass spectrometric analysis. Toxicol Appl Pharmacol 2008; 226:206-11
12. Divi RL, Leonard SL, Kuo MM, et al. Cardiac mitochondrial compromise in 1-yr-old Erythrocebus patas monkeys perinatally-exposed to nucleoside reverse transcriptase inhibitors. Cardiovasc Toxicol 2005; 5:333-46 (Pubitemid 41506873)
13. Divi RL, Einem TL, Fletcher SL, et al. Progressive mitochondrial compromise in brains and livers of primates exposed in utero to nucleoside reverse transcriptase inhibitors (NRTIs). Toxicol Sci 2010; 118: 191-201
14. Peloponese JM Jr, Haller K, Miyazato A, Jeang KT. Abnormal centrosome amplification in cells through the targeting of Ran-binding protein-1 by the human T cell leukemia virus type-1 Tax oncoprotein. Proc Natl Acad Sci USA 2005; 102:18974-9 (Pubitemid 43049551)
15. Andre-Schmutz A, Dal-Cortivo L, Six E, et al. Genotoxic signature in cord blood cells of newborns exposed in utero to a zidovudine-based antiretroviral combination. J Infec Dis 2013; 208:235-43.